These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 7850839)

  • 1. Current status of biodegradable stents.
    Tanguay JF; Zidar JP; Phillips HR; Stack RS
    Cardiol Clin; 1994 Nov; 12(4):699-713. PubMed ID: 7850839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical strategies for development of intracoronary stents].
    Dong W; Li J; Li F
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 1997 Jun; 14(2):156-63. PubMed ID: 9817646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Standards in interventional therapy of coronary artery disease].
    Rutsch W; Gliech V; Dübel HP; Borges A; Theres H; Laule M; Baumann G
    Herz; 2002 Sep; 27(6):481-501. PubMed ID: 12378393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug-eluting stents.
    García-García HM; Vaina S; Tsuchida K; Serruys PW
    Arch Cardiol Mex; 2006; 76(3):297-319. PubMed ID: 17091802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug-eluting stents: role of stent design, delivery vehicle, and drug selection.
    Rodgers CD
    Rev Cardiovasc Med; 2002; 3 Suppl 5():S10-5. PubMed ID: 12478230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coronary stents in the management of coronary artery disease review of first 100 stents.
    Ng SC; Sawatt C; Foo LK; Hitam O; Khor PG; Lee YK
    Med J Malaysia; 1996 Mar; 51(1):75-9. PubMed ID: 10967983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymers, drug release, and drug-eluting stents.
    Commandeur S; van Beusekom HM; van der Giessen WJ
    J Interv Cardiol; 2006 Dec; 19(6):500-6. PubMed ID: 17107364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Update on PTCA: what are its limitations? Can they be overcome by new devices? A look at atherectomy, intra-arterial stents, and laser catheters.
    Feldman T; Moscucci M
    J Crit Illn; 1993 Apr; 8(4):461-78. PubMed ID: 10148463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Local drug administration systems, preclinical and clinical use: perspectives and limitations].
    Gonschior P; Wilensky R; March K; Höfling B
    Z Kardiol; 1996 Mar; 85(3):155-65. PubMed ID: 8659193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphorylcholine-coated stents.
    Lewis AL; Stratford PW
    J Long Term Eff Med Implants; 2002; 12(4):231-50. PubMed ID: 12627785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of clinical outcome after elective and "bail out" coronary stent insertion.
    Robinson NM; Thomas MR; Jewitt DE; Wainwright RJ
    J Invasive Cardiol; 1995; 7(6):156-64. PubMed ID: 10155100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effective and efficient strategies for coronary revascularization in the drug-eluting stent era.
    Lepor NE; Madyoon H; Kereiakes D
    Rev Cardiovasc Med; 2002; 3 Suppl 5():S38-50. PubMed ID: 12478234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Latin American randomized trial of balloon angioplasty versus coronary stenting in diabetic patients with small vessel reference size (Latin American Small Vessel [LASMAL II] Trial): immediate and long-term results.
    Rodriguez AE; Rodriguez Alemparte M; Fernandez Pereira C; Vigo CF; Sampaolesi A; Bernardi V; Marchand E; Tronge J; Palacios IF;
    Am Heart J; 2005 Jul; 150(1):188. PubMed ID: 16086559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of coronary artery stents on mortality and nonfatal myocardial infarction: meta-analysis of randomized trials comparing a strategy of routine stenting with that of balloon angioplasty.
    Al Suwaidi J; Holmes DR; Salam AM; Lennon R; Berger PB
    Am Heart J; 2004 May; 147(5):815-22. PubMed ID: 15131536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stent coatings and local drug delivery; state of the art.
    Gunn J; Cumberland D
    Eur Heart J; 1999 Dec; 20(23):1693-700. PubMed ID: 10562476
    [No Abstract]   [Full Text] [Related]  

  • 16. Local drug delivery in restenosis injury: thermoresponsive co-polymers as potential drug delivery systems.
    Kavanagh CA; Rochev YA; Gallagher WM; Dawson KA; Keenan AK
    Pharmacol Ther; 2004 Apr; 102(1):1-15. PubMed ID: 15056495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug-eluting stent: the emerging technique for the prevention of restenosis.
    Sheiban I; Carrieri L; Catuzzo B; Destefanis P; Oliaro E; Moretti C; Trevi GP
    Minerva Cardioangiol; 2002 Oct; 50(5):443-53. PubMed ID: 12384626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [New intervention procedures: lasers, atherectomy, stents].
    Schömig A; Seyfarth M; Kastrati A
    Z Kardiol; 1993; 82 Suppl 5():127-31. PubMed ID: 8154151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [New strategies in the treatment of restenosis].
    von Hodenberg E; Tost B; Scheffold T
    Z Kardiol; 2000; 89 Suppl 7():19-22. PubMed ID: 11098555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Is Palmaz-Schatz stenting effective for second restenosis?].
    Kishi K; Hiasa Y; Suzuki N; Miyamoto H; Takahashi T; Hosokawa S; Tanimoto M; Otani R
    J Cardiol; 1999 Nov; 34(5):243-8. PubMed ID: 10579132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.